Efficacy and Safety Study of Jaktinib in Subjects With Active Ankylosing Spondylitis(AS)
Clinical trial NCT05861102 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05861102
- Sponsor
- Suzhou Zelgen Biopharmaceuticals Co.,Ltd
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-20
- Primary completion
- 2026-05-01
- Enrollment
- 265
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.